First Eagle Value In Biotechnology Master Fund, Ltd. - Net Worth and Insider Trading

First Eagle Value In Biotechnology Master Fund, Ltd. Net Worth

The estimated net worth of First Eagle Value In Biotechnology Master Fund, Ltd. is at least $42,647 dollars as of 2024-11-05. First Eagle Value In Biotechnology Master Fund, Ltd. is the See remarks. of Aradigm Corp and owns about 927,107 shares of Aradigm Corp (ARDMQ) stock worth over $42,647. Details can be seen in First Eagle Value In Biotechnology Master Fund, Ltd.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that First Eagle Value In Biotechnology Master Fund, Ltd. has not made any transactions after 2009-02-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of First Eagle Value In Biotechnology Master Fund, Ltd.

First Eagle Value In Biotechnology Master Fund, Ltd. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, First Eagle Value In Biotechnology Master Fund, Ltd. owns 3 companies in total, including Durect Corp (DRRX) , Aradigm Corp (ARDMQ) , and Intevac Inc (IVAC) .

Click here to see the complete history of First Eagle Value In Biotechnology Master Fund, Ltd.’s form 4 insider trades.

Insider Ownership Summary of First Eagle Value In Biotechnology Master Fund, Ltd.

Ticker	Comapny	Transaction Date	Type of Owner
DRRX	Durect Corp	2015-03-17	10 percent owner
ARDMQ	Aradigm Corp	2019-05-01	10 percent owner
IVAC	Intevac Inc	2017-04-24	10 percent owner

First Eagle Value In Biotechnology Master Fund, Ltd. Latest Holdings Summary

First Eagle Value In Biotechnology Master Fund, Ltd. currently owns a total of 1 stock. First Eagle Value In Biotechnology Master Fund, Ltd. owns 927,107 shares of Aradigm Corp (ARDMQ) as of February 23, 2009, with a value of $42,647.

Latest Holdings of First Eagle Value In Biotechnology Master Fund, Ltd.

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
ARDMQ	Aradigm Corp	2009-02-23	927,107	0.05	42,647

Holding Weightings of First Eagle Value In Biotechnology Master Fund, Ltd.

First Eagle Value In Biotechnology Master Fund, Ltd. Form 4 Trading Tracker

According to the SEC Form 4 filings, First Eagle Value In Biotechnology Master Fund, Ltd. has made a total of 0 transactions in Aradigm Corp (ARDMQ) over the past 5 years. The most-recent trade in Aradigm Corp is the sale of 0 shares on February 23, 2009, which brought First Eagle Value In Biotechnology Master Fund, Ltd. around $0.

Insider Trading History of First Eagle Value In Biotechnology Master Fund, Ltd.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

First Eagle Value In Biotechnology Master Fund, Ltd. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

First Eagle Value In Biotechnology Master Fund, Ltd. Ownership Network

Ownership Network List of First Eagle Value In Biotechnology Master Fund, Ltd.

No Data

Ownership Network Relation of First Eagle Value In Biotechnology Master Fund, Ltd.

First Eagle Value In Biotechnology Master Fund, Ltd. Owned Company Details

What does Durect Corp do?

Who are the key executives at Durect Corp?

First Eagle Value In Biotechnology Master Fund, Ltd. is the 10 percent owner of Durect Corp. Other key executives at Durect Corp include Chief Financial Officer Timothy M. Papp , Chief Medical Officer Norman Sussman , and 10 percent owner Bleichroeder Lp .

Durect Corp (DRRX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Durect Corp (DRRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Durect Corp (DRRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Durect Corp (DRRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Durect Corp Insider Transactions

No Available Data

What does Aradigm Corp do?

Who are the key executives at Aradigm Corp?

First Eagle Value In Biotechnology Master Fund, Ltd. is the 10 percent owner of Aradigm Corp. Other key executives at Aradigm Corp include 10 percent owner Bleichroeder Lp , 10 percent owner First Eagle Investment Management, Llc , and 10 percent owner 21 April Fund Lp .

Aradigm Corp (ARDMQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aradigm Corp (ARDMQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aradigm Corp (ARDMQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aradigm Corp (ARDMQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aradigm Corp Insider Transactions

No Available Data

What does Intevac Inc do?

Who are the key executives at Intevac Inc?

First Eagle Value In Biotechnology Master Fund, Ltd. is the 10 percent owner of Intevac Inc. Other key executives at Intevac Inc include Chief Financial Officer, Kevin Soulsby , director & President and CEO Nigel Hunton , and Chief Financial Officer, James P Moniz .

Intevac Inc (IVAC) Insider Trades Summary

Over the past 18 months, First Eagle Value In Biotechnology Master Fund, Ltd. made no insider transaction in Intevac Inc (IVAC). Other recent insider transactions involving Intevac Inc (IVAC) include a net purchase of 5,000 shares made by James P Moniz , a net purchase of 5,000 shares made by Nigel Hunton , and a net purchase of 5,000 shares made by Michele Klein .

In summary, during the past 3 months, insiders sold 0 shares of Intevac Inc (IVAC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Intevac Inc (IVAC) were sold and 15,000 shares were bought by its insiders, resulting in a net purchase of 15,000 shares.

Intevac Inc (IVAC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Intevac Inc Insider Transactions

No Available Data

First Eagle Value In Biotechnology Master Fund, Ltd. Mailing Address

Above is the net worth, insider trading, and ownership report for First Eagle Value In Biotechnology Master Fund, Ltd.. You might contact First Eagle Value In Biotechnology Master Fund, Ltd. via mailing address: C/o First Eagle Investment Management, 1345 Avenue Of The Americas, 48th Floor, New York Ny 10105.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.